Connecting clinical care, data and research
PartnershipsContact
← Back to publications

RESEARCH PUBLICATION / 2025

Correspondence / Letter

Unexplored limitations in a randomized trial that examines efficacy and safety of upadacitinib or elsubrutinib alone or in combination for patients with systemic lupus erythematosus: comment on the article by Merrill et al.

Arthritis & Rheumatology

Citation & Authors

Arthritis Rheumatol. 2025;77(8):1108.

Qianyu Guo; Junkang Zhao; Li-Yun Zhang; James Cheng-Chung Wei

Abstract & Original paper

No abstract is available in the public index. Please consult the original paper.

Go to journal page